HEADER TRANSFERASE/INHIBITOR 30-JUN-22 8DJC TITLE CRYSTAL STRUCTURE OF GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH TITLE 2 (4S)-N-{4-[(2S)-2-METHYLMORPHOLIN-4-YL] PYRIDIN-3-YL}-2- TITLE 3 PHENYLIMIDAZO[1,2-B]PYRIDAZINE-8-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN SYNTHASE KINASE-3 BETA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GSK-3 BETA,SERINE/THREONINE-PROTEIN KINASE GSK3B; COMPND 5 EC: 2.7.11.26,2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GSK3B; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, GSK3B, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX, KEYWDS 2 TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.A.LEWIS,J.K.MUCKELBAUER REVDAT 3 03-APR-24 8DJC 1 REMARK REVDAT 2 05-APR-23 8DJC 1 JRNL REVDAT 1 22-MAR-23 8DJC 0 JRNL AUTH R.A.HARTZ,V.T.AHUJA,P.SIVAPRAKASAM,H.XIAO,C.M.KRAUSE, JRNL AUTH 2 W.J.CLARKE,K.KISH,H.LEWIS,N.SZAPIEL,R.RAVIRALA,S.MUTALIK, JRNL AUTH 3 D.NAKMODE,D.SHAH,C.R.BURTON,J.E.MACOR,G.M.DUBOWCHIK JRNL TITL DESIGN, STRUCTURE-ACTIVITY RELATIONSHIPS, AND IN VIVO JRNL TITL 2 EVALUATION OF POTENT AND BRAIN-PENETRANT IMIDAZO[1,2- B JRNL TITL 3 ]PYRIDAZINES AS GLYCOGEN SYNTHASE KINASE-3 BETA (GSK-3 BETA JRNL TITL 4 ) INHIBITORS. JRNL REF J.MED.CHEM. V. 66 4231 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 36950863 JRNL DOI 10.1021/ACS.JMEDCHEM.3C00133 REMARK 2 REMARK 2 RESOLUTION. 2.46 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.46 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.7 REMARK 3 NUMBER OF REFLECTIONS : 41160 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.870 REMARK 3 FREE R VALUE TEST SET COUNT : 2003 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.46 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.48 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 787 REMARK 3 BIN R VALUE (WORKING SET) : 0.2973 REMARK 3 BIN FREE R VALUE : 0.3155 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.49 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 37 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5090 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 81 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.66 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.87 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.06570 REMARK 3 B22 (A**2) : -10.67060 REMARK 3 B33 (A**2) : 14.73630 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.340 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.275 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.217 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.283 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.222 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.923 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.903 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5331 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7331 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1716 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 952 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5287 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 713 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3899 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.90 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.09 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.95 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS WERE FULLY REFINED WITH ZERO REMARK 3 OCCUPANCY AT NUCLEAR POSITION. REFINEMENT NOTES. NUMBER OF REMARK 3 REFINEMENT NOTES : 1 NOTE 1 : IDEAL-DIST CONTACT TERM CONTACT REMARK 3 SETUP. ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 8DJC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000266567. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-NOV-16 REMARK 200 TEMPERATURE (KELVIN) : 100.000 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : KIRKPATRICK-BAEZ MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.27 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41287 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.460 REMARK 200 RESOLUTION RANGE LOW (A) : 89.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.6 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.10100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.46 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.74100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: UNPUBLISHED MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 6.0, 20.0 %W/V PEG6K, 0.2 REMARK 280 M NH4CL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.48950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 89.24100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.00150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 89.24100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.48950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.00150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -20 REMARK 465 HIS A -19 REMARK 465 SER A -18 REMARK 465 SER A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 SER A -10 REMARK 465 SER A -9 REMARK 465 GLY A -8 REMARK 465 GLU A -7 REMARK 465 ASN A -6 REMARK 465 LEU A -5 REMARK 465 TYR A -4 REMARK 465 PHE A -3 REMARK 465 GLN A -2 REMARK 465 GLY A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 ARG A 4 REMARK 465 PRO A 5 REMARK 465 ARG A 6 REMARK 465 THR A 7 REMARK 465 THR A 8 REMARK 465 SER A 9 REMARK 465 PHE A 10 REMARK 465 ALA A 11 REMARK 465 GLU A 12 REMARK 465 SER A 13 REMARK 465 CYS A 14 REMARK 465 LYS A 15 REMARK 465 PRO A 16 REMARK 465 VAL A 17 REMARK 465 GLN A 18 REMARK 465 GLN A 19 REMARK 465 PRO A 20 REMARK 465 SER A 21 REMARK 465 ALA A 22 REMARK 465 PHE A 23 REMARK 465 GLY A 24 REMARK 465 SER A 25 REMARK 465 MET A 26 REMARK 465 LYS A 27 REMARK 465 VAL A 28 REMARK 465 SER A 29 REMARK 465 ARG A 30 REMARK 465 ASP A 31 REMARK 465 LYS A 32 REMARK 465 ASP A 33 REMARK 465 GLY A 34 REMARK 465 GLY A 120 REMARK 465 GLU A 121 REMARK 465 LYS A 122 REMARK 465 ASN A 285 REMARK 465 PRO A 286 REMARK 465 ASN A 287 REMARK 465 TYR A 288 REMARK 465 THR A 289 REMARK 465 GLU A 290 REMARK 465 PHE A 291 REMARK 465 LYS A 292 REMARK 465 PHE A 293 REMARK 465 PRO A 294 REMARK 465 GLN A 295 REMARK 465 ILE A 296 REMARK 465 LYS A 297 REMARK 465 ALA A 298 REMARK 465 ARG A 383 REMARK 465 ILE A 384 REMARK 465 GLN A 385 REMARK 465 ALA A 386 REMARK 465 ALA A 387 REMARK 465 ALA A 388 REMARK 465 SER A 389 REMARK 465 THR A 390 REMARK 465 PRO A 391 REMARK 465 THR A 392 REMARK 465 ASN A 393 REMARK 465 ALA A 394 REMARK 465 THR A 395 REMARK 465 ALA A 396 REMARK 465 ALA A 397 REMARK 465 SER A 398 REMARK 465 ASP A 399 REMARK 465 ALA A 400 REMARK 465 ASN A 401 REMARK 465 THR A 402 REMARK 465 GLY A 403 REMARK 465 ASP A 404 REMARK 465 ARG A 405 REMARK 465 GLY A 406 REMARK 465 GLN A 407 REMARK 465 THR A 408 REMARK 465 ASN A 409 REMARK 465 ASN A 410 REMARK 465 ALA A 411 REMARK 465 ALA A 412 REMARK 465 SER A 413 REMARK 465 ALA A 414 REMARK 465 SER A 415 REMARK 465 ALA A 416 REMARK 465 SER A 417 REMARK 465 ASN A 418 REMARK 465 SER A 419 REMARK 465 THR A 420 REMARK 465 MET B -20 REMARK 465 HIS B -19 REMARK 465 SER B -18 REMARK 465 SER B -17 REMARK 465 HIS B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 SER B -10 REMARK 465 SER B -9 REMARK 465 GLY B -8 REMARK 465 GLU B -7 REMARK 465 ASN B -6 REMARK 465 LEU B -5 REMARK 465 TYR B -4 REMARK 465 PHE B -3 REMARK 465 GLN B -2 REMARK 465 GLY B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 GLY B 3 REMARK 465 ARG B 4 REMARK 465 PRO B 5 REMARK 465 ARG B 6 REMARK 465 THR B 7 REMARK 465 THR B 8 REMARK 465 SER B 9 REMARK 465 PHE B 10 REMARK 465 ALA B 11 REMARK 465 GLU B 12 REMARK 465 SER B 13 REMARK 465 CYS B 14 REMARK 465 LYS B 15 REMARK 465 PRO B 16 REMARK 465 VAL B 17 REMARK 465 GLN B 18 REMARK 465 GLN B 19 REMARK 465 PRO B 20 REMARK 465 SER B 21 REMARK 465 ALA B 22 REMARK 465 PHE B 23 REMARK 465 GLY B 24 REMARK 465 SER B 25 REMARK 465 MET B 26 REMARK 465 LYS B 27 REMARK 465 VAL B 28 REMARK 465 SER B 29 REMARK 465 ARG B 30 REMARK 465 ASP B 31 REMARK 465 LYS B 32 REMARK 465 ASP B 33 REMARK 465 GLY B 34 REMARK 465 GLY B 120 REMARK 465 GLU B 121 REMARK 465 LYS B 122 REMARK 465 ASN B 285 REMARK 465 PRO B 286 REMARK 465 ASN B 287 REMARK 465 TYR B 288 REMARK 465 THR B 289 REMARK 465 GLU B 290 REMARK 465 PHE B 291 REMARK 465 LYS B 292 REMARK 465 PHE B 293 REMARK 465 PRO B 294 REMARK 465 GLN B 295 REMARK 465 ILE B 296 REMARK 465 LYS B 297 REMARK 465 ALA B 298 REMARK 465 HIS B 299 REMARK 465 PRO B 300 REMARK 465 ALA B 386 REMARK 465 ALA B 387 REMARK 465 ALA B 388 REMARK 465 SER B 389 REMARK 465 THR B 390 REMARK 465 PRO B 391 REMARK 465 THR B 392 REMARK 465 ASN B 393 REMARK 465 ALA B 394 REMARK 465 THR B 395 REMARK 465 ALA B 396 REMARK 465 ALA B 397 REMARK 465 SER B 398 REMARK 465 ASP B 399 REMARK 465 ALA B 400 REMARK 465 ASN B 401 REMARK 465 THR B 402 REMARK 465 GLY B 403 REMARK 465 ASP B 404 REMARK 465 ARG B 405 REMARK 465 GLY B 406 REMARK 465 GLN B 407 REMARK 465 THR B 408 REMARK 465 ASN B 409 REMARK 465 ASN B 410 REMARK 465 ALA B 411 REMARK 465 ALA B 412 REMARK 465 SER B 413 REMARK 465 ALA B 414 REMARK 465 SER B 415 REMARK 465 ALA B 416 REMARK 465 SER B 417 REMARK 465 ASN B 418 REMARK 465 SER B 419 REMARK 465 THR B 420 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 36 CD CE NZ REMARK 470 GLN A 46 CG CD OE1 NE2 REMARK 470 GLU A 53 CG CD OE1 OE2 REMARK 470 LYS A 60 NZ REMARK 470 SER A 66 OG REMARK 470 LYS A 74 CE NZ REMARK 470 ASP A 77 CG OD1 OD2 REMARK 470 SER A 78 OG REMARK 470 LYS A 91 CG CD CE NZ REMARK 470 ARG A 92 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 93 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 94 CG CD CE NZ REMARK 470 GLN A 99 CG CD OE1 NE2 REMARK 470 LYS A 123 CG CD CE NZ REMARK 470 ASP A 124 CG OD1 OD2 REMARK 470 GLU A 125 CG CD OE1 OE2 REMARK 470 LYS A 150 CG CD CE NZ REMARK 470 GLN A 185 CG CD OE1 NE2 REMARK 470 ARG A 209 NE CZ NH1 NH2 REMARK 470 ARG A 220 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 278 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 279 CG CD OE1 OE2 REMARK 470 ILE A 281 CD1 REMARK 470 ARG A 282 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 283 CD OE1 OE2 REMARK 470 LYS A 303 CG CD CE NZ REMARK 470 ARG A 306 CZ NH1 NH2 REMARK 470 ARG A 308 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 355 CG OD1 OD2 REMARK 470 LYS B 36 CG CD CE NZ REMARK 470 LYS B 60 CE NZ REMARK 470 LYS B 74 CE NZ REMARK 470 ASP B 77 CG OD1 OD2 REMARK 470 LYS B 91 CG CD CE NZ REMARK 470 ARG B 92 CD NE CZ NH1 NH2 REMARK 470 PHE B 93 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 94 CG CD CE NZ REMARK 470 LYS B 103 CE NZ REMARK 470 SER B 119 OG REMARK 470 LYS B 123 CG CD CE NZ REMARK 470 ASP B 124 CG OD1 OD2 REMARK 470 GLU B 125 CG CD OE1 OE2 REMARK 470 ARG B 144 NH1 NH2 REMARK 470 LYS B 150 CG CD CE NZ REMARK 470 GLN B 151 CG CD OE1 NE2 REMARK 470 ARG B 220 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 271 CE NZ REMARK 470 ARG B 278 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 279 CG CD OE1 OE2 REMARK 470 ARG B 282 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 303 CG CD CE NZ REMARK 470 ARG B 306 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 308 CG CD NE CZ NH1 NH2 REMARK 470 ILE B 376 CD1 REMARK 470 GLN B 385 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 49 83.90 -64.43 REMARK 500 ASP A 181 46.21 -149.93 REMARK 500 ASP A 200 84.27 68.46 REMARK 500 CYS A 218 139.06 83.11 REMARK 500 TYR A 221 -28.78 95.96 REMARK 500 ASN A 370 77.14 -161.37 REMARK 500 ASP B 49 82.48 -62.98 REMARK 500 ASP B 181 45.99 -150.55 REMARK 500 ASP B 200 83.27 59.65 REMARK 500 CYS B 218 138.29 82.24 REMARK 500 TYR B 221 -32.04 98.12 REMARK 500 ASN B 370 77.33 -161.12 REMARK 500 REMARK 500 REMARK: NULL DBREF 8DJC A 1 420 UNP P49841 GSK3B_HUMAN 1 420 DBREF 8DJC B 1 420 UNP P49841 GSK3B_HUMAN 1 420 SEQADV 8DJC MET A -20 UNP P49841 INITIATING METHIONINE SEQADV 8DJC HIS A -19 UNP P49841 EXPRESSION TAG SEQADV 8DJC SER A -18 UNP P49841 EXPRESSION TAG SEQADV 8DJC SER A -17 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS A -16 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS A -15 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS A -14 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS A -13 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS A -12 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS A -11 UNP P49841 EXPRESSION TAG SEQADV 8DJC SER A -10 UNP P49841 EXPRESSION TAG SEQADV 8DJC SER A -9 UNP P49841 EXPRESSION TAG SEQADV 8DJC GLY A -8 UNP P49841 EXPRESSION TAG SEQADV 8DJC GLU A -7 UNP P49841 EXPRESSION TAG SEQADV 8DJC ASN A -6 UNP P49841 EXPRESSION TAG SEQADV 8DJC LEU A -5 UNP P49841 EXPRESSION TAG SEQADV 8DJC TYR A -4 UNP P49841 EXPRESSION TAG SEQADV 8DJC PHE A -3 UNP P49841 EXPRESSION TAG SEQADV 8DJC GLN A -2 UNP P49841 EXPRESSION TAG SEQADV 8DJC GLY A -1 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS A 0 UNP P49841 EXPRESSION TAG SEQADV 8DJC MET B -20 UNP P49841 INITIATING METHIONINE SEQADV 8DJC HIS B -19 UNP P49841 EXPRESSION TAG SEQADV 8DJC SER B -18 UNP P49841 EXPRESSION TAG SEQADV 8DJC SER B -17 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS B -16 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS B -15 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS B -14 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS B -13 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS B -12 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS B -11 UNP P49841 EXPRESSION TAG SEQADV 8DJC SER B -10 UNP P49841 EXPRESSION TAG SEQADV 8DJC SER B -9 UNP P49841 EXPRESSION TAG SEQADV 8DJC GLY B -8 UNP P49841 EXPRESSION TAG SEQADV 8DJC GLU B -7 UNP P49841 EXPRESSION TAG SEQADV 8DJC ASN B -6 UNP P49841 EXPRESSION TAG SEQADV 8DJC LEU B -5 UNP P49841 EXPRESSION TAG SEQADV 8DJC TYR B -4 UNP P49841 EXPRESSION TAG SEQADV 8DJC PHE B -3 UNP P49841 EXPRESSION TAG SEQADV 8DJC GLN B -2 UNP P49841 EXPRESSION TAG SEQADV 8DJC GLY B -1 UNP P49841 EXPRESSION TAG SEQADV 8DJC HIS B 0 UNP P49841 EXPRESSION TAG SEQRES 1 A 441 MET HIS SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 441 GLU ASN LEU TYR PHE GLN GLY HIS MET SER GLY ARG PRO SEQRES 3 A 441 ARG THR THR SER PHE ALA GLU SER CYS LYS PRO VAL GLN SEQRES 4 A 441 GLN PRO SER ALA PHE GLY SER MET LYS VAL SER ARG ASP SEQRES 5 A 441 LYS ASP GLY SER LYS VAL THR THR VAL VAL ALA THR PRO SEQRES 6 A 441 GLY GLN GLY PRO ASP ARG PRO GLN GLU VAL SER TYR THR SEQRES 7 A 441 ASP THR LYS VAL ILE GLY ASN GLY SER PHE GLY VAL VAL SEQRES 8 A 441 TYR GLN ALA LYS LEU CYS ASP SER GLY GLU LEU VAL ALA SEQRES 9 A 441 ILE LYS LYS VAL LEU GLN ASP LYS ARG PHE LYS ASN ARG SEQRES 10 A 441 GLU LEU GLN ILE MET ARG LYS LEU ASP HIS CYS ASN ILE SEQRES 11 A 441 VAL ARG LEU ARG TYR PHE PHE TYR SER SER GLY GLU LYS SEQRES 12 A 441 LYS ASP GLU VAL TYR LEU ASN LEU VAL LEU ASP TYR VAL SEQRES 13 A 441 PRO GLU THR VAL TYR ARG VAL ALA ARG HIS TYR SER ARG SEQRES 14 A 441 ALA LYS GLN THR LEU PRO VAL ILE TYR VAL LYS LEU TYR SEQRES 15 A 441 MET TYR GLN LEU PHE ARG SER LEU ALA TYR ILE HIS SER SEQRES 16 A 441 PHE GLY ILE CYS HIS ARG ASP ILE LYS PRO GLN ASN LEU SEQRES 17 A 441 LEU LEU ASP PRO ASP THR ALA VAL LEU LYS LEU CYS ASP SEQRES 18 A 441 PHE GLY SER ALA LYS GLN LEU VAL ARG GLY GLU PRO ASN SEQRES 19 A 441 VAL SER TYR ILE CYS SER ARG TYR TYR ARG ALA PRO GLU SEQRES 20 A 441 LEU ILE PHE GLY ALA THR ASP TYR THR SER SER ILE ASP SEQRES 21 A 441 VAL TRP SER ALA GLY CYS VAL LEU ALA GLU LEU LEU LEU SEQRES 22 A 441 GLY GLN PRO ILE PHE PRO GLY ASP SER GLY VAL ASP GLN SEQRES 23 A 441 LEU VAL GLU ILE ILE LYS VAL LEU GLY THR PRO THR ARG SEQRES 24 A 441 GLU GLN ILE ARG GLU MET ASN PRO ASN TYR THR GLU PHE SEQRES 25 A 441 LYS PHE PRO GLN ILE LYS ALA HIS PRO TRP THR LYS VAL SEQRES 26 A 441 PHE ARG PRO ARG THR PRO PRO GLU ALA ILE ALA LEU CYS SEQRES 27 A 441 SER ARG LEU LEU GLU TYR THR PRO THR ALA ARG LEU THR SEQRES 28 A 441 PRO LEU GLU ALA CYS ALA HIS SER PHE PHE ASP GLU LEU SEQRES 29 A 441 ARG ASP PRO ASN VAL LYS LEU PRO ASN GLY ARG ASP THR SEQRES 30 A 441 PRO ALA LEU PHE ASN PHE THR THR GLN GLU LEU SER SER SEQRES 31 A 441 ASN PRO PRO LEU ALA THR ILE LEU ILE PRO PRO HIS ALA SEQRES 32 A 441 ARG ILE GLN ALA ALA ALA SER THR PRO THR ASN ALA THR SEQRES 33 A 441 ALA ALA SER ASP ALA ASN THR GLY ASP ARG GLY GLN THR SEQRES 34 A 441 ASN ASN ALA ALA SER ALA SER ALA SER ASN SER THR SEQRES 1 B 441 MET HIS SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 441 GLU ASN LEU TYR PHE GLN GLY HIS MET SER GLY ARG PRO SEQRES 3 B 441 ARG THR THR SER PHE ALA GLU SER CYS LYS PRO VAL GLN SEQRES 4 B 441 GLN PRO SER ALA PHE GLY SER MET LYS VAL SER ARG ASP SEQRES 5 B 441 LYS ASP GLY SER LYS VAL THR THR VAL VAL ALA THR PRO SEQRES 6 B 441 GLY GLN GLY PRO ASP ARG PRO GLN GLU VAL SER TYR THR SEQRES 7 B 441 ASP THR LYS VAL ILE GLY ASN GLY SER PHE GLY VAL VAL SEQRES 8 B 441 TYR GLN ALA LYS LEU CYS ASP SER GLY GLU LEU VAL ALA SEQRES 9 B 441 ILE LYS LYS VAL LEU GLN ASP LYS ARG PHE LYS ASN ARG SEQRES 10 B 441 GLU LEU GLN ILE MET ARG LYS LEU ASP HIS CYS ASN ILE SEQRES 11 B 441 VAL ARG LEU ARG TYR PHE PHE TYR SER SER GLY GLU LYS SEQRES 12 B 441 LYS ASP GLU VAL TYR LEU ASN LEU VAL LEU ASP TYR VAL SEQRES 13 B 441 PRO GLU THR VAL TYR ARG VAL ALA ARG HIS TYR SER ARG SEQRES 14 B 441 ALA LYS GLN THR LEU PRO VAL ILE TYR VAL LYS LEU TYR SEQRES 15 B 441 MET TYR GLN LEU PHE ARG SER LEU ALA TYR ILE HIS SER SEQRES 16 B 441 PHE GLY ILE CYS HIS ARG ASP ILE LYS PRO GLN ASN LEU SEQRES 17 B 441 LEU LEU ASP PRO ASP THR ALA VAL LEU LYS LEU CYS ASP SEQRES 18 B 441 PHE GLY SER ALA LYS GLN LEU VAL ARG GLY GLU PRO ASN SEQRES 19 B 441 VAL SER TYR ILE CYS SER ARG TYR TYR ARG ALA PRO GLU SEQRES 20 B 441 LEU ILE PHE GLY ALA THR ASP TYR THR SER SER ILE ASP SEQRES 21 B 441 VAL TRP SER ALA GLY CYS VAL LEU ALA GLU LEU LEU LEU SEQRES 22 B 441 GLY GLN PRO ILE PHE PRO GLY ASP SER GLY VAL ASP GLN SEQRES 23 B 441 LEU VAL GLU ILE ILE LYS VAL LEU GLY THR PRO THR ARG SEQRES 24 B 441 GLU GLN ILE ARG GLU MET ASN PRO ASN TYR THR GLU PHE SEQRES 25 B 441 LYS PHE PRO GLN ILE LYS ALA HIS PRO TRP THR LYS VAL SEQRES 26 B 441 PHE ARG PRO ARG THR PRO PRO GLU ALA ILE ALA LEU CYS SEQRES 27 B 441 SER ARG LEU LEU GLU TYR THR PRO THR ALA ARG LEU THR SEQRES 28 B 441 PRO LEU GLU ALA CYS ALA HIS SER PHE PHE ASP GLU LEU SEQRES 29 B 441 ARG ASP PRO ASN VAL LYS LEU PRO ASN GLY ARG ASP THR SEQRES 30 B 441 PRO ALA LEU PHE ASN PHE THR THR GLN GLU LEU SER SER SEQRES 31 B 441 ASN PRO PRO LEU ALA THR ILE LEU ILE PRO PRO HIS ALA SEQRES 32 B 441 ARG ILE GLN ALA ALA ALA SER THR PRO THR ASN ALA THR SEQRES 33 B 441 ALA ALA SER ASP ALA ASN THR GLY ASP ARG GLY GLN THR SEQRES 34 B 441 ASN ASN ALA ALA SER ALA SER ALA SER ASN SER THR HET UAU A 501 53 HET UAU B 501 53 HETNAM UAU (4S)-N-{4-[(2S)-2-METHYLMORPHOLIN-4-YL]PYRIDIN-3-YL}-2- HETNAM 2 UAU PHENYLIMIDAZO[1,2-B]PYRIDAZINE-8-CARBOXAMIDE FORMUL 3 UAU 2(C23 H22 N6 O2) FORMUL 5 HOH *81(H2 O) HELIX 1 AA1 ASN A 95 LYS A 103 1 9 HELIX 2 AA2 VAL A 139 ALA A 149 1 11 HELIX 3 AA3 PRO A 154 PHE A 175 1 22 HELIX 4 AA4 LYS A 183 GLN A 185 5 3 HELIX 5 AA5 ALA A 224 PHE A 229 1 6 HELIX 6 AA6 SER A 236 GLY A 253 1 18 HELIX 7 AA7 SER A 261 GLY A 274 1 14 HELIX 8 AA8 THR A 277 MET A 284 1 8 HELIX 9 AA9 PRO A 300 PHE A 305 5 6 HELIX 10 AB1 PRO A 310 LEU A 321 1 12 HELIX 11 AB2 THR A 324 ARG A 328 5 5 HELIX 12 AB3 THR A 330 ALA A 336 1 7 HELIX 13 AB4 HIS A 337 ASP A 345 5 9 HELIX 14 AB5 THR A 363 SER A 368 1 6 HELIX 15 AB6 ASN A 370 PRO A 372 5 3 HELIX 16 AB7 LEU A 373 ILE A 378 1 6 HELIX 17 AB8 ASN B 95 LYS B 103 1 9 HELIX 18 AB9 VAL B 139 ALA B 149 1 11 HELIX 19 AC1 PRO B 154 PHE B 175 1 22 HELIX 20 AC2 LYS B 183 GLN B 185 5 3 HELIX 21 AC3 ALA B 224 PHE B 229 1 6 HELIX 22 AC4 SER B 236 GLY B 253 1 18 HELIX 23 AC5 SER B 261 GLY B 274 1 14 HELIX 24 AC6 THR B 277 MET B 284 1 8 HELIX 25 AC7 TRP B 301 PHE B 305 5 5 HELIX 26 AC8 PRO B 310 LEU B 321 1 12 HELIX 27 AC9 THR B 324 ARG B 328 5 5 HELIX 28 AD1 THR B 330 ALA B 336 1 7 HELIX 29 AD2 HIS B 337 ASP B 345 5 9 HELIX 30 AD3 THR B 363 SER B 368 1 6 HELIX 31 AD4 ASN B 370 PRO B 372 5 3 HELIX 32 AD5 LEU B 373 ILE B 378 1 6 HELIX 33 AD6 PRO B 379 ILE B 384 1 6 SHEET 1 AA1 7 THR A 38 PRO A 44 0 SHEET 2 AA1 7 GLN A 52 ASN A 64 -1 O VAL A 54 N VAL A 40 SHEET 3 AA1 7 VAL A 69 LEU A 75 -1 O LYS A 74 N THR A 57 SHEET 4 AA1 7 LEU A 81 LEU A 88 -1 O LYS A 86 N VAL A 69 SHEET 5 AA1 7 TYR A 127 ASP A 133 -1 O LEU A 132 N ALA A 83 SHEET 6 AA1 7 LEU A 112 SER A 118 -1 N SER A 118 O TYR A 127 SHEET 7 AA1 7 THR A 38 PRO A 44 -1 N THR A 43 O PHE A 115 SHEET 1 AA2 3 GLU A 137 THR A 138 0 SHEET 2 AA2 3 LEU A 187 ASP A 190 -1 O LEU A 189 N GLU A 137 SHEET 3 AA2 3 VAL A 195 LEU A 198 -1 O LYS A 197 N LEU A 188 SHEET 1 AA3 2 ILE A 177 CYS A 178 0 SHEET 2 AA3 2 LYS A 205 GLN A 206 -1 O LYS A 205 N CYS A 178 SHEET 1 AA4 7 THR B 38 PRO B 44 0 SHEET 2 AA4 7 GLN B 52 ASN B 64 -1 O VAL B 54 N VAL B 40 SHEET 3 AA4 7 VAL B 69 LEU B 75 -1 O LYS B 74 N THR B 57 SHEET 4 AA4 7 LEU B 81 LEU B 88 -1 O LYS B 86 N VAL B 69 SHEET 5 AA4 7 TYR B 127 ASP B 133 -1 O LEU B 132 N ALA B 83 SHEET 6 AA4 7 LEU B 112 SER B 118 -1 N SER B 118 O TYR B 127 SHEET 7 AA4 7 THR B 38 PRO B 44 -1 N THR B 43 O PHE B 115 SHEET 1 AA5 3 GLU B 137 THR B 138 0 SHEET 2 AA5 3 LEU B 187 ASP B 190 -1 O LEU B 189 N GLU B 137 SHEET 3 AA5 3 VAL B 195 LEU B 198 -1 O LYS B 197 N LEU B 188 SHEET 1 AA6 2 ILE B 177 CYS B 178 0 SHEET 2 AA6 2 LYS B 205 GLN B 206 -1 O LYS B 205 N CYS B 178 CRYST1 82.979 86.003 178.482 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012051 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011628 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005603 0.00000